Nuzenio

Wild Type

Wild Type news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 03:24:28 GMTDr Brufsky on the FDA Approval of Gedatolisib Plus Fulvestrant ± Palbociclib in PIK3CA Wild-Type Breast Cancer - OncLive
Thu, 06 Aug 2026 11:19:22 GMTEvIDHence Study: Real-World Outcomes in IDH1-Mutant and Wild-Type Cholangiocarcinoma Before mIDH1 Inhibitors - Oncodaily
Mon, 03 Aug 2026 15:13:18 GMTNCCN Guidelines Add Gedatolisib-Based Regimens for Pretreated PIK3CA Wild-Type Advanced Breast Cancer - OncLive
Fri, 31 Jul 2026 21:16:29 GMTToxicity Considerations With Third-Line Treatment in KRAS Wild-Type mCRC - Targeted Oncology
Fri, 31 Jul 2026 20:06:29 GMTSelinexor Maintenance Misses Mark in TP53 Wild-Type Endometrial Cancer - Targeted Oncology
Fri, 31 Jul 2026 17:22:55 GMTSelinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - OncLive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Wild Type.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.